Literature DB >> 91841

Abnormal intestinal permeability to sugars in villous atrophy.

I S Menzies, M F Laker, R Pounder, J Bull, S Heyer, P G Wheeler, B Creamer.   

Abstract

Intestinal permeability to a monosaccharide and a disaccharide was compared by simultaneous measurement of the urinary excretion of L-rhamnose and lactulose after oral ingestion of an hypertonic solution containing both sugars. Urine samples were analysed for sugar content by quantitative thin-layer or paper chromatography. Results in thirteen patients with untreated villous atrophy were compared with those in twelve healthy volunteers. Urinary L-rhamnose excretion was significantly decreased (-40%, p less than 0.02) in patients with villous atrophy, whereas lactulose excretion was paradoxically and significantly increased (+345%, p less than 0.01). The median value of the lactulose/L-rhamnose urinary excretion ratio was sevenfold higher in the patients with villous atrophy; there was no overlap of values for patients and volunteers (p less than 0.01). It is postulated that reduced L-rhamnose urinary excretion in untreated villous atrophy is due to a decreased absorptive area in the small bowel, whereas increased lactulose excretion indicates leakiness of the abnormal mucosa to larger polar molecules.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 91841     DOI: 10.1016/s0140-6736(79)92507-8

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  74 in total

1.  Intestinal permeability in adult patients with growth hormone deficiency.

Authors:  J García-Arnés; C Sierra; F Tinahones; A Monzón; M J López; N Mazuecos; F Soriguer; E Valverde
Journal:  J Endocrinol Invest       Date:  2001-02       Impact factor: 4.256

2.  Measurement of small intestinal permeability markers, lactulose, and mannitol in serum: results in celiac disease.

Authors:  M A Cox; K O Lewis; B T Cooper
Journal:  Dig Dis Sci       Date:  1999-02       Impact factor: 3.199

3.  Clinical tests of gastrointestinal permeability that rely on the urinary recovery of enterally administered probes can yield invalid results in critically ill patients.

Authors:  Mitchell P Fink
Journal:  Intensive Care Med       Date:  2002-01-12       Impact factor: 17.440

4.  Non-invasive assessment of barrier integrity and function of the human gut.

Authors:  Joep Grootjans; Geertje Thuijls; Froukje Verdam; Joep Pm Derikx; Kaatje Lenaerts; Wim A Buurman
Journal:  World J Gastrointest Surg       Date:  2010-03-27

5.  Intestinal mucosal permeability of severely underweight and nonmalnourished Bangladeshi children and effects of nutritional rehabilitation.

Authors:  Md Iqbal Hossain; Baitun Nahar; Jena D Hamadani; Tahmeed Ahmed; Anjan Kumar Roy; Kenneth H Brown
Journal:  J Pediatr Gastroenterol Nutr       Date:  2010-11       Impact factor: 2.839

6.  The digestive adaptation of flying vertebrates: high intestinal paracellular absorption compensates for smaller guts.

Authors:  Enrique Caviedes-Vidal; Todd J McWhorter; Shana R Lavin; Juan G Chediack; Christopher R Tracy; William H Karasov
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-19       Impact factor: 11.205

7.  [14C]-triolein absorption: a useful test in the diagnosis of malabsorption.

Authors:  J M Turner; S Lawrence; I W Fellows; I Johnson; P G Hill; G K Holmes
Journal:  Gut       Date:  1987-06       Impact factor: 23.059

8.  Serum IgG subclass antibodies to gliadin and other dietary antigens in children with coeliac disease.

Authors:  S Husby; N Foged; V A Oxelius; S E Svehag
Journal:  Clin Exp Immunol       Date:  1986-06       Impact factor: 4.330

9.  Small intestinal permeability to mannitol, lactulose, and polyethylene glycol 400 in celiac disease.

Authors:  S O Ukabam; B T Cooper
Journal:  Dig Dis Sci       Date:  1984-09       Impact factor: 3.199

10.  Cellobiose/mannitol sugar permeability test complements biopsy histopathology in clinical investigation of the jejunum.

Authors:  S Strobel; W G Brydon; A Ferguson
Journal:  Gut       Date:  1984-11       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.